QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
NASDAQ:CHEK

Check-Cap - CHEK Stock Forecast, Price & News

$3.61
-0.01 (-0.28%)
(As of 12/6/2022 12:00 AM ET)
Add
Compare
Today's Range
$3.53
$4.00
50-Day Range
$2.90
$5.90
52-Week Range
$2.90
$16.40
Volume
82,328 shs
Average Volume
41,253 shs
Market Capitalization
$17.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Check-Cap MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
1.17% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.01mentions of Check-Cap in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($3.50) to ($3.30) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.53 out of 5 stars

CHEK stock logo

About Check-Cap (NASDAQ:CHEK) Stock

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.

Receive CHEK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Check-Cap and its competitors with MarketBeat's FREE daily newsletter.

CHEK Stock News Headlines

Fact-checking Liz Truss at PMQs - BBC
Potential Gold Rush For Investors Sparked By USA Vs. China Trade War
Right now, China has the US Military in a stranglehold. They hold a monopoly on one of our most CRITICAL defense elements. But thanks to executive orders from both Biden and Trump...
Potential Gold Rush For Investors Sparked By USA Vs. China Trade War
Right now, China has the US Military in a stranglehold. They hold a monopoly on one of our most CRITICAL defense elements. But thanks to executive orders from both Biden and Trump...
See More Headlines
Receive CHEK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Check-Cap and its competitors with MarketBeat's FREE daily newsletter.

CHEK Company Calendar

Last Earnings
11/03/2021
Today
12/06/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
X - ray apparatus & tubes
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CHEK
Employees
65
Year Founded
N/A

Profitability

Net Income
$-17,200,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$10.52 per share

Miscellaneous

Free Float
N/A
Market Cap
$17.40 million
Optionable
Not Optionable
Beta
0.30

Key Executives

  • Mr. Alex Ovadia (Age 60)
    CEO & Director
    Comp: $539.3k
  • Dr. Yoav Kimchy Ph.D. (Age 61)
    Founder & Chief Technology Officer
    Comp: $445.07k
  • Ms. Mira Rosenzweig (Age 50)
    Chief Financial Officer
    Comp: $330.65k
  • Mr. Joshua Belkar (Age 53)
    VP of Operations
    Comp: $291.32k
  • Ms. Noa Reshef M.B.A.
    Director of HR













CHEK Stock - Frequently Asked Questions

Should I buy or sell Check-Cap stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Check-Cap in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CHEK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CHEK, but not buy additional shares or sell existing shares.
View CHEK analyst ratings
or view top-rated stocks.

How have CHEK shares performed in 2022?

Check-Cap's stock was trading at $13.4940 at the beginning of 2022. Since then, CHEK stock has decreased by 73.3% and is now trading at $3.60.
View the best growth stocks for 2022 here
.

Are investors shorting Check-Cap?

Check-Cap saw a decline in short interest in the month of November. As of November 15th, there was short interest totaling 56,500 shares, a decline of 94.3% from the October 31st total of 998,500 shares. Based on an average daily volume of 26,800 shares, the short-interest ratio is presently 2.1 days.
View Check-Cap's Short Interest
.

How were Check-Cap's earnings last quarter?

Check-Cap Ltd. (NASDAQ:CHEK) issued its quarterly earnings data on Wednesday, November, 3rd. The medical research company reported ($0.80) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($1.00) by $0.20.

When did Check-Cap's stock split?

Check-Cap's stock reverse split before market open on Friday, November 25th 2022. The 1-20 reverse split was announced on Friday, November 25th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, November 25th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Check-Cap own?
When did Check-Cap IPO?

(CHEK) raised $13 million in an initial public offering on Thursday, February 19th 2015. The company issued 1,200,000 shares at $10.00-$12.00 per share. Chardan Capital Markets and Maxim Group acted as the underwriters for the IPO and Feltl and Company was co-manager.

What is Check-Cap's stock symbol?

Check-Cap trades on the NASDAQ under the ticker symbol "CHEK."

Who are Check-Cap's major shareholders?

Check-Cap's stock is owned by a number of institutional and retail investors. Top institutional investors include Citadel Advisors LLC (0.15%) and Virtu Financial LLC (0.13%).

How do I buy shares of Check-Cap?

Shares of CHEK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Check-Cap's stock price today?

One share of CHEK stock can currently be purchased for approximately $3.60.

How much money does Check-Cap make?

Check-Cap (NASDAQ:CHEK) has a market capitalization of $17.35 million. The medical research company earns $-17,200,000.00 in net income (profit) each year or ($3.24) on an earnings per share basis.

How can I contact Check-Cap?

Check-Cap's mailing address is 29 ABBA HUSHI AVE. P.O.BOX 1271, ISFIYA L3, 3009000. The official website for the company is www.check-cap.com. The medical research company can be reached via phone at 972546706451, via email at jeremy@lifesciadvisors.com, or via fax at 972-4821-1267.

This page (NASDAQ:CHEK) was last updated on 12/6/2022 by MarketBeat.com Staff